Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Gene Editing, Indiscriminate Degradation And Recyclic Catalytic Events In Crispr Cas Technology

Version 1 : Received: 26 January 2024 / Approved: 28 January 2024 / Online: 29 January 2024 (09:42:28 CET)

How to cite: Nazir, D.T.; A. Mirza, H.; Radwan, S.; Taha, N. Gene Editing, Indiscriminate Degradation And Recyclic Catalytic Events In Crispr Cas Technology. Preprints 2024, 2024011947. https://doi.org/10.20944/preprints202401.1947.v1 Nazir, D.T.; A. Mirza, H.; Radwan, S.; Taha, N. Gene Editing, Indiscriminate Degradation And Recyclic Catalytic Events In Crispr Cas Technology. Preprints 2024, 2024011947. https://doi.org/10.20944/preprints202401.1947.v1

Abstract

In "genome editing," a type of genetic engineering, DNA is added, taken away, or changed in an organism's genome. Biomedicine, biotechnology, and synthetic biology, just to name a few, have all gained a lot from how often this method is used. Before the editing process can start, a Double-Strand Breaks (DSB) must be made in the DNA at a specific gene. Researchers have made nucleases, which are sometimes called "molecular scissors," to fix this DSB. Transcription activator-like effector nucleases (TALENs), Zinc-finger nucleases (ZFNs), and homing endonucleases are all examples of protein targets that have been studied and changed. The last part gave an overview of these study projects and explained how to make Cas12a for specific uses. The applications of Cas12a have been extensively studied in recent years, but the protein still holds a lot of promise as a treatment and screening tool. In order to give a quick review of CRISPR-Cas12a and its uses, we will briefly talk about the structure and function of the different parts of the reaction pathway that lead up to the catalysis of the target DNA. Cas12a uses a multistep process to make sure that it is selecting the right DNA. This is a good trait for a device that changes the DNA because it makes it less likely that something bad will happen. Even though data shows that a new CRISPR RNAs (crRNA) molecule can stop Cas12a from randomly destroying ssDNA, it may still hurt the host cell while trying to change the genome. The action of Cas12a catalysis, which is a powerful tool for changing the genome, needs to be changed so that it can be more easily controlled and managed. Using what we know about how Cas12a works, we have made mutants that are less active on ssDNA and more active on dsDNA. So far, only Cas9 and Cas12a, which are both part of the CRISPR family, have been used to change the genome. Because of how similar and different these two endonucleases are, CRISPR can now be used for multiple scientific purposes. Cas12a is better than Cas9 because it makes double-strand breaks (DSBs) that favor Homology-Directed Repair (HDR) over Non-homologous end joining (NHEJ) and can change more than one copy of the genome at the same time. Both Cas9 and Cas12a are being changed to make them better at detecting Protospacer Adjacent Motif (PAM) than they are in their natural state. This will make it possible to start focusing on more genes.

Keywords

CRISPR-Cas12a, RNA guided endonucleases, crRNA biogenesis, Indiscriminate ssDNAse, Endonuclease recycling. 

Subject

Biology and Life Sciences, Biochemistry and Molecular Biology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.